Article Per Year (5 Year)
p-Index From 2020 - 2025
0.444
P-Index
This Author published in this journals
All Journal Budapest International Research in Exact Sciences (BirEx Journal) Britain International of Exact Sciences Journal (BIoEx Journal)
Ruphin Djolu Djoza
Unknown Affiliation
Agriculture, Biological Sciences & Forestry Biochemistry, Genetics & Molecular Biology Chemistry Civil Engineering, Building, Construction & Architecture Mathematics Medicine & Pharmacology Physics Transportation

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Congolese Medicinal Plant biodiversity as Source of AntiCOVID-19 Compounds: Economic goods in the light of Comparative Advantages Theory of Ricardo Modeste Ndaba Modeawi; Ruphin Djolu Djoza; Colette Masengo Ashande; Clarisse Falanga Mawi; Emmanuel Moke Lengbiye; Clément Inkoto Liyongo; Benjamin Gbolo Zoawe; Muhammad Ridwan; Pius T. Mpiana; Mudogo Virima; Koto-te-Nyiwa Ngbolua
Budapest International Research in Exact Sciences (BirEx) Journal Vol 2, No 3 (2020): Budapest International Research in Exact Sciences, July
Publisher : Budapest International Research and Critics University

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33258/birex.v2i3.1067

Abstract

Since the outbreak of Covid-19 (Corona virus) in China in December 2019, the disease has killed more people in Europa, America and Asia according to official sources.  Less impacted than the rest of the world, Africa as well as Oceania has less confirmed cases and less deaths. In countries whose health systems are among the most fragile in the world, with far less resources than those mobilized in Europe, China or the United States, the situation in Africa is potentially catastrophic. Since human and material resources, such as hospitalization and intensive care beds, are largely insufficient, the mortality rate linked to Covid-19 is likely to be 3 to 5 times higher than in the rest of the world. In the face of this evidence, scientific research based on medicinal plants would be seen as no less important part of the solution to the Covid-19 pandemic, based on plant biodiversity. The Malagasy Institute of Applied Research (IMRA/Madagascar) on the basis of the Artemisia annua has set up Covid-Organics; The Congolese plant biodiversity offers undeniable advantages for the setting up of an Improved Traditional Medicine following the example of Covid-Organics. This would constitute for the Democratic Republic of the Congo a comparative advantage to be put forward in its multiple international exchanges.
Serious Side Effects Associated with the Administration of Johnson & Johnson COVID-19 Antigens after Immunisation: A Case Report from the Wapinda Health Area (North-Ubangi) in the Democratic Republic of the Congo Vincent Danvene Gonda; Modeste Ndaba Modeawi; Ruphin Djolu Djoza; Colette Masengo Ashande; Koto-Te-Nyiwa Jean-Paul Ngbolua
Britain International of Exact Sciences (BIoEx) Journal Vol 6 No 1 (2024): Britain International of Exact Sciences Journal, January
Publisher : Britain International for Academic Research (BIAR) Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33258/bioex.v6i1.1040

Abstract

On March 10, 2020, the Democratic Republic of the Congo (DRC) declared the onset of the COVID-19 pandemic. Since then, there have been a total of 95,738 cases, comprising 95,736 confirmed cases and 2 probable cases, with 84,321 recoveries and 1,464 fatalities. Following the guidance of the World Health Organization (WHO), African nations have been actively working to establish and expand vaccination programs. Starting the vaccination campaign in the DRC on April 19, 2021, a total of 10,893,593 individuals, estimated to be 20.18% of the target population, have received vaccines. Among them, 882,106 individuals, or 1.65%, have received their first dose, while 8,576,320 individuals or 15.89% of the target population, and have been fully vaccinated. The Democratic Republic of the Congo aims to vaccinate 53.9 million people against COVID-19, according to the technical response secretariat. This article focuses on the post-vaccination symptoms observed in a resident of the Wapinda sector, Yakoma territory in Nord-Ubangi Province, which has raised curiosity and serves as the subject of discussion.
Co-Authors Benjamin Gbolo Zoawe Clarisse Falanga Mawi Clement Inkoto Liyongo Colette Masengo Ashande Emmanuel Moke Lengbiye Koto-Te-Nyiwa Jean-Paul Ngbolua Koto-te-Nyiwa Ngbolua Modeste Ndaba Modeawi Mudogo Virima Muhammad Ridwan Pius T. Mpiana Vincent Danvene Gonda